Goodwill and Other Intangible Assets

12 Months Ended

Jun. 30, 2025

Goodwill and Intangible Assets Disclosure [Abstract]

5. Goodwill and Other Intangible Assets

Goodwill

The following table summarizes the changes in the carrying amount of goodwill for the two reportable segments and the remaining operating segments, included in Other and in total:


(in millions)	Pharmaceutical and Specialty Solutions		Global Medical Products and Distribution (1)		Other (2) (3)		Total
Balance at June 30, 2023	$	2,762	$	681	$	1,170	$	4,613
Goodwill acquired, net of purchase price adjustments	793		(3)		—		790
Foreign currency translation adjustments and other	—		(3)		—		(3)
Goodwill Impairment	—		(675)		—		(675)

Balance at June 30, 2024	$	3,555	$	—	$	1,170	$	4,725
Goodwill acquired, net of purchase price adjustments	4,389		—		578		4,967
Foreign currency translation adjustments and other	(1)		—		—		(1)


Balance at June 30, 2025	$	7,943	$	—	$	1,748	$	9,691

(1) At June 30, 2025 and 2024, the GMPD segment accumulated goodwill impairment loss was $5.4 billion.

(2) At June 30, 2025 and 2024, the Nuclear and Precision Health Solutions accumulated goodwill impairment loss was $829 million.

(3) Comprised of the remaining operating segments, Nuclear and Precision Health Solutions, at-Home Solutions, and OptiFreight® Logistics.

The increase in the Pharma segment goodwill is primarily due to the GIA and ION acquisitions that occurred during fiscal 2025. The increase in the Other segment goodwill is due to the ADS acquisition that occurred during fiscal 2025. Goodwill recognized in connection with these acquisitions primarily represent the expected benefits from the expected growth from new customers, the assembled workforce of the acquired entities, and synergies of integrating these businesses. Substantially all of the goodwill recorded is expected to be nondeductible for income tax purposes.

During fiscal 2025, we did not identify any indicators of impairment within our reporting units.

We performed interim quantitative goodwill impairment testing for GMPD at September 30, 2023 and March 31, 2024, which resulted in pre-tax goodwill impairment charges of $585 million and $90 million, respectively. GMPD goodwill was fully impaired during the third quarter of fiscal 2024. During fiscal 2023, GMPD had cumulative pre-tax impairment charges of $1.2 billion. These goodwill impairment charges are recorded in impairments and

(gain)/loss on disposal of assets, net in our consolidated statements of earnings.

In connection with the divestiture of the Outcomes business, during fiscal 2023, we allocated and reclassified $24 million of goodwill from the Pharma operating segment to the Outcomes disposal group based on the estimated relative fair values of the business to be disposed of and the portion of the reporting unit that was retained.

Other Intangible Assets

The following tables summarize other intangible assets by class at June 30:


	2025
(in millions)	Gross Intangible		Accumulated Amortization		Net Intangible		Weighted- Average Remaining Amortization Period (Years)
Indefinite-life intangibles:
Trademarks and patents	$	13	$	—	$	13	N/A
Total indefinite-life intangibles	13		—		13		N/A
Definite-life intangibles:
Customer intangibles	3,876		2,639		1,237		11
Trademarks, trade names, and patents	1,340		459		881		8
Developed technology and other	1,030		726		304		6
Non-Competition Agreements	72		21		51		4
Total definite-life intangibles	6,318		3,845		2,473		10
Total other intangible assets	$	6,331	$	3,845	$	2,486	N/A


	2024
(in millions)	Gross Intangible		Accumulated Amortization		Net Intangible
Indefinite-life intangibles:
Trademarks and patents	$	12	$	—	$	12
Total indefinite-life intangibles	12		—		12
Definite-life intangibles:
Customer intangibles	3,628		2,431		1,197
Trademarks, trade names, and patents	561		408		153
Developed technology and other	1,047		684		363
Total definite-life intangibles	5,236		3,523		1,713
Total other intangible assets	$	5,248	$	3,523	$	1,725

The increase in definite-life intangibles is primarily due to the ADS, GIA, and ION acquisitions. Total amortization of intangible assets was $303 million, $264 million, and $281 million for fiscal 2025, 2024, and 2023, respectively. The estimated annual amortization for intangible assets for fiscal 2026 through 2030 is as follows: $360 million, $364 million, $330 million, $307 million, and $284 million.